ES549378A0 - Procedimiento para la preparacion de derivados de 1,3,4-tia-diazol - Google Patents

Procedimiento para la preparacion de derivados de 1,3,4-tia-diazol

Info

Publication number
ES549378A0
ES549378A0 ES549378A ES549378A ES549378A0 ES 549378 A0 ES549378 A0 ES 549378A0 ES 549378 A ES549378 A ES 549378A ES 549378 A ES549378 A ES 549378A ES 549378 A0 ES549378 A0 ES 549378A0
Authority
ES
Spain
Prior art keywords
diazole
tia
derivatives
procedure
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES549378A
Other languages
English (en)
Other versions
ES8700245A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Heumann Ludwig and Co GmbH
Original Assignee
Heumann Ludwig and Co GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heumann Ludwig and Co GmbH filed Critical Heumann Ludwig and Co GmbH
Publication of ES8700245A1 publication Critical patent/ES8700245A1/es
Publication of ES549378A0 publication Critical patent/ES549378A0/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/121,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C07D285/1251,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C07D285/135Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES549378A 1985-04-12 1985-11-28 Procedimiento para la preparacion de derivados de 1,3,4-tia-diazol Expired ES8700245A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19853513184 DE3513184A1 (de) 1985-04-12 1985-04-12 1,3,4-thiadiazolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Publications (2)

Publication Number Publication Date
ES8700245A1 ES8700245A1 (es) 1986-10-16
ES549378A0 true ES549378A0 (es) 1986-10-16

Family

ID=6267864

Family Applications (1)

Application Number Title Priority Date Filing Date
ES549378A Expired ES8700245A1 (es) 1985-04-12 1985-11-28 Procedimiento para la preparacion de derivados de 1,3,4-tia-diazol

Country Status (14)

Country Link
US (1) US4738960A (es)
EP (1) EP0197189A3 (es)
JP (1) JPS61238782A (es)
KR (1) KR860008172A (es)
AU (1) AU578766B2 (es)
DE (1) DE3513184A1 (es)
DK (1) DK501385A (es)
ES (1) ES8700245A1 (es)
GR (1) GR852573B (es)
HU (1) HU196064B (es)
IL (1) IL77097A0 (es)
NZ (1) NZ214231A (es)
PT (1) PT81409B (es)
ZA (1) ZA858841B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR228941A1 (es) * 1978-04-26 1983-05-13 Glaxo Group Ltd Procedimiento para preparar nuevos derivados de 3,5-diamino-1,2,4-triazol que son activos contra receptores histaminicos
JPS60255756A (ja) * 1984-06-01 1985-12-17 Ikeda Mohandou:Kk アミノアルキルフエノキシ誘導体
CA1275097A (en) * 1984-10-02 1990-10-09 Fujio Nohara Pyridyloxy derivatives
WO2022034121A1 (en) 2020-08-11 2022-02-17 Université De Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3118126A1 (de) * 1981-05-07 1982-12-02 Bayer Ag, 5090 Leverkusen Sulfenamide zur verwendung in arzneimitteln
US4600779A (en) * 1982-03-29 1986-07-15 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
US4578471A (en) * 1982-03-29 1986-03-25 Bristol-Myers Company Substituted amino alkyl pyridyl ethanediimidamides
US4440933A (en) * 1983-03-16 1984-04-03 Bristol-Myers Company Process for preparing 1,2,5-thiadiazoles
JPS59196879A (ja) * 1983-04-08 1984-11-08 Wakamoto Pharmaceut Co Ltd 新規な1,3,4−チアジアゾ−ル誘導体
JPS6067474A (ja) * 1983-09-24 1985-04-17 Wakamoto Pharmaceut Co Ltd 新規な1,3,4−チアジアゾ−ル誘導体及びそれを有効成分とする抗潰瘍剤
DE3341750A1 (de) * 1983-11-18 1985-05-30 Ludwig Heumann & Co GmbH, 8500 Nürnberg 1,2,4-triazolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
JPS60255756A (ja) * 1984-06-01 1985-12-17 Ikeda Mohandou:Kk アミノアルキルフエノキシ誘導体
DE3441086A1 (de) * 1984-11-09 1986-05-15 Ludwig Heumann & Co GmbH, 8500 Nürnberg 3,4-diazolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Also Published As

Publication number Publication date
IL77097A0 (en) 1986-04-29
DE3513184A1 (de) 1986-10-16
GR852573B (es) 1986-08-13
ES8700245A1 (es) 1986-10-16
JPS61238782A (ja) 1986-10-24
HU196064B (en) 1988-09-28
EP0197189A2 (de) 1986-10-15
US4738960A (en) 1988-04-19
AU578766B2 (en) 1988-11-03
ZA858841B (en) 1986-07-30
DK501385D0 (da) 1985-10-31
EP0197189A3 (de) 1987-05-27
HUT44525A (en) 1988-03-28
NZ214231A (en) 1988-07-28
PT81409B (de) 1987-04-13
DK501385A (da) 1986-10-13
PT81409A (de) 1985-11-01
KR860008172A (ko) 1986-11-12
AU5024185A (en) 1986-10-16

Similar Documents

Publication Publication Date Title
MX162864B (es) Procedimiento para la preparacion de 2,2,6,6-tetraalquil-4-piperidilaminas
ES553138A0 (es) Procedimiento para la preparacion de 3-ariluracilos
ES551625A0 (es) Procedimiento para la preparacion de 13-alquil-ll b -fenil-gonamos
ES546484A0 (es) Procedimiento para la preparacion de derivados de furazano
MX7769A (es) Procedimiento para la preparacion de derivados de pirimidina.
ES555434A0 (es) Procedimiento para la preparacion de benzoil-ureas
ES2007557B3 (es) Procedimiento para la preparacion de (2,2)- paraciclofano.
ES551069A0 (es) Procedimiento para la preparacion de derivados de 13beta-alquil-milbenicina
ES556514A0 (es) Procedimiento para la preparacion de derivados de 2-oxi-4h-3, 1-benzoxazin-4-ona
ES551485A0 (es) Procedimiento para la preparacion de derivados de all-cis-1,3,5-triamino-2,4,6-trihidrociclohexano
ES546908A0 (es) Procedimiento para la preparacion de derivados de fenilace- tonitrilo
ES557423A0 (es) Procedimiento para la preparacion de derivados de 1,4-dihidropiridina
ES549378A0 (es) Procedimiento para la preparacion de derivados de 1,3,4-tia-diazol
ES554860A0 (es) Procedimiento para la preparacion de 4,4,7-trimetil-3,4,7,8-tetrahidro-2 (6h)-naftalin-ona
ES556590A0 (es) Procedimiento para la obtencion de derivados de piridazo(1,2-a)(1,2)diacepina
MX159632A (es) Procedimiento para la preparacion de derivados de pirimidina 2,4,6,triona
ES554339A0 (es) Procedimiento para la obtencion de derivados de 1,4-dihidropiridina
ES557233A0 (es) Procedimiento para la preparacion de 3-ariluracilos
ES549906A0 (es) Procedimiento para la preparacion de derivados de 1,4-dihi- dropiridina
ES541884A0 (es) Procedimiento para la preparacion de derivados de 10-amino- tieno (3,2) (1,5) benzotiazepinas
ES549380A0 (es) Procedimiento para la preparacion de derivados de piperacina
ES551575A0 (es) Procedimiento para la preparacion de nuevos derivados pirrol
ES537427A0 (es) Procedimiento para la preparacion de derivados de 1, 4-dihidropiridinas
ES537424A0 (es) Procedimiento para la preparacion de derivados de 1, 4-dihidropiridinas
ES549163A0 (es) Procedimiento para la preparacion de la 1-cinamil-4- benzi- drilpiperazina